Literature DB >> 7918920

Review article: gastro-oesophageal reflux and laryngeal symptoms.

A G Fraser1.   

Abstract

There is some evidence from clinical, experimental and multiprobe ambulatory pH studies that gastro-oesophageal reflux is more common in patients with laryngeal symptoms and could potentially play a role in the causation of these symptoms. The proportion of unselected patients with laryngeal symptoms who have gastro-oesophageal reflux as the primary aetiology may be overestimated in some series. The symptom that has been most evaluated is hoarseness, but even for this symptom the proportion of patients who have significant reflux varies widely. There is even less agreement for other symptoms, and the data on globus sensation remains confused. It is likely that these patients present to ear, nose and throat (ENT) clinics because of the relative insensitivity of the oesophageal mucosa to acid exposure. Given the lack of specificity for routine diagnostic tests for gastro-oesophageal reflux, it is necessary to perform ambulatory pH monitoring for a secure diagnosis in these patients. Treatment studies have been surprisingly few and inadequate in design. It is suspected that there is a strong placebo response for these symptoms. No clear information on efficacy can be provided until placebo-controlled randomised studies are available.

Entities:  

Mesh:

Year:  1994        PMID: 7918920     DOI: 10.1111/j.1365-2036.1994.tb00287.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  13 in total

1.  Effect of omeprazole on the course of associated esophagitis and laryngitis.

Authors:  D Jaspersen; R Weber; C H Hammar; W Draf
Journal:  J Gastroenterol       Date:  1996-12       Impact factor: 7.527

2.  Is the proton pump inhibitor test helpful in patients with laryngeal symptoms?

Authors:  Jeong Hwan Kim; In-Kyung Sung; Sung Noh Hong; Sun-Young Lee; Hyung Seok Park; Chan Sup Shim
Journal:  Dig Dis Sci       Date:  2013-02-27       Impact factor: 3.199

3.  Healing of severe esophagitis improves esophageal peristaltic dysfunction.

Authors:  P Deprez; R Fiasse
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

Review 4.  Molecular pathways and genetic factors in the pathogenesis of laryngopharyngeal reflux.

Authors:  Alexios S Vardouniotis; Alexander D Karatzanis; Eleni Tzortzaki; Elias Athanasakis; Katerina D Samara; Georgios Chalkiadakis; Nikolaos Siafakas; George A Velegrakis
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-02       Impact factor: 2.503

5.  Laryngopharyngeal reflux: Current opinion.

Authors:  K K Handa
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2005-07

6.  [Stenosing gastric laryngitis in infancy].

Authors:  A Hennig; A Neumann; H-J Schultz-Coulon
Journal:  HNO       Date:  2004-04       Impact factor: 1.284

7.  Open-Label Observational Study for Evaluating the Short-term Benefits of Rabeprazole Medication on Laryngopharyngeal Reflux.

Authors:  Myung-Hee Shin; Soon Yuhl Nam; Young-Hak Park; Young-Ik Son
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-03-22       Impact factor: 3.372

8.  Nizatidine Improves Impaired Salivary Secretion in GERD.

Authors:  Yoshihisa Urita; Toshiyasu Watanabe; Kazuo Hike; Makie Nanami; Tadashi Maeda; Yosuke Sasaki; Asuka Nakayama; Takamasa Ishii; Kaoru Domon; Susumu Ishihara; Masaki Sanaka; Hitoshi Nakajima; Motonobu Sugimoto
Journal:  Clin Med Case Rep       Date:  2008-08-19

Review 9.  Laryngopharyngeal reflux: diagnosis, treatment, and latest research.

Authors:  Andrea Maria Campagnolo; Jaqueline Priston; Rebecca Heidrich Thoen; Tatiana Medeiros; Aída Regina Assunção
Journal:  Int Arch Otorhinolaryngol       Date:  2013-11-05

10.  Relationship between gastroesophageal reflux disease and Ph nose and salivary: proposal of a simple method outpatient in patients adults.

Authors:  Arturo Armone Caruso; Salvatore Del Prete; Lydia Ferrara; Luigi Sivero; Raffaele Serra; Donato Alessandro Telesca; Simona Ruggiero; Teresa Russo
Journal:  Open Med (Wars)       Date:  2016-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.